• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Gene profiling for pressure ulcer

Research Project

Project/Area Number 17KT0046
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeMulti-year Fund
Section特設分野
Research Field Complex Systems Disease Theory
Research InstitutionKeio University

Principal Investigator

NISHIHARA Hiroshi  慶應義塾大学, 医学部(信濃町), 教授 (50322805)

Co-Investigator(Kenkyū-buntansha) 松崎 典弥  大阪大学, 工学研究科, 教授 (00419467)
角五 彰  北海道大学, 理学研究院, 准教授 (10374224)
柳 輝希  北海道大学, 大学病院, 助教 (50755973)
繁富 香織  北海道大学, 高等教育推進機構, 特任准教授 (90431816)
Project Period (FY) 2017-07-18 – 2020-03-31
Project Status Completed (Fiscal Year 2019)
Budget Amount *help
¥18,590,000 (Direct Cost: ¥14,300,000、Indirect Cost: ¥4,290,000)
Fiscal Year 2019: ¥2,730,000 (Direct Cost: ¥2,100,000、Indirect Cost: ¥630,000)
Fiscal Year 2018: ¥5,590,000 (Direct Cost: ¥4,300,000、Indirect Cost: ¥1,290,000)
Fiscal Year 2017: ¥10,270,000 (Direct Cost: ¥7,900,000、Indirect Cost: ¥2,370,000)
Keywords褥瘡 / 病理 / 臨床 / 生体医工学 / 細胞シート / 圧負荷 / 臨床病理学的解析 / 組織 / PDGFRbeta / alpha-SMA / メカノセンサー / 肉芽 / 良性・悪性 / 人に皮膚モデル / 遺伝子プロファイル / メカノバイオロジー / 個別化治療
Outline of Final Research Achievements

Our research aim was to clarify the mechanism of pressure ulcer and try to establish the personalized treatment for the patients with pressure ulcer. Through this research, we have performed clinico-pathological evaluation for up to 200 cases. In results, we could divided pressure ulcer into two types depending on the mechanism. In addition, we explore the involvement of PDGFRb as a responsible factor for pressure ulcer.
We also performed biotechnological approach to establish the Ex vivo model for pressure ulcer, but we could not make cell sheet with strength enough for experimental pressure test. Achievement rate of our original research aim would be evaluated as 40%.

Academic Significance and Societal Importance of the Research Achievements

我々の研究成果により、褥瘡の臨床病理学的分類が明確となり、最適な治療法を選択することが可能となる。また、今後の研究の発展により、より詳細な発症に寄与する因子が同定されれば、新たな治療薬、治療法の開発も期待できる。

Report

(4 results)
  • 2019 Annual Research Report   Final Research Report ( PDF )
  • 2018 Research-status Report
  • 2017 Research-status Report
  • Research Products

    (2 results)

All 2020 2019

All Journal Article (2 results) (of which Int'l Joint Research: 1 results,  Peer Reviewed: 2 results,  Open Access: 1 results)

  • [Journal Article] Intratumoral Genomic Heterogeneity May Hinder Precision Medicine Strategies in Patients with Serous Ovarian Carcinoma2020

    • Author(s)
      Nakamura Kohei、Aimono Eriko、Tanishima Shigeki、Imai Mitsuho、Nagatsuma Akiko Kawano、Hayashi Hideyuki、Yoshimura Yuki、Nakayama Kentaro、Kyo Satoru、Nishihara Hiroshi
    • Journal Title

      Diagnostics

      Volume: 10 Issue: 4 Pages: 200-200

    • DOI

      10.3390/diagnostics10040200

    • Related Report
      2019 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Cancer gene profiling explores the possible precision medicine for diffuse-type gastric adenocarcinoma2019

    • Author(s)
      Ishikawa M, Hayashi H, Sakamoto N, Tanaka S, Nishihara H
    • Journal Title

      Med Oncol.

      Volume: 37(1) Issue: 1 Pages: 10-10

    • DOI

      10.1007/s12032-019-1327-4

    • Related Report
      2019 Annual Research Report
    • Peer Reviewed

URL: 

Published: 2017-07-21   Modified: 2021-02-19  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi